Dr Jeanette Pritchard

Manager, Imaging Delivery & Sensing

Nanotechnology Victoria Ltd

Suite 201, Level 2, 3 Chester Street
PH: +61 (3) 95673708
Fax: +61 (3) 95681214
Email: [email protected]


Dr Jeanette Pritchard joined Nanotechnology Victoria Ltd. in May 2006, as part of the Delivery and Sensing Team. Jeanettes primary focus has been to develop NanoVics Diagnostics portfolio, with particular emphasis on medical imaging for the in vivo detection of human diseases. During her time at NanoVic, Jeanette has been responsible for managing three Demonstration Projects and also for securing funds towards a $1.5 million imaging program, with the University of Melbourne and Baker Heart Research Institute. Jeanette has also been instrumental in the formation of Quintain NanoSystems, the vehicle established for commercialisation of NanoVics diagnostic imaging activities, with the focus being the development of nanoparticle-based targeted contrast agents. An integral part of establishing Quintain NS has been the production of the Business Plan, which was recently completed in close collaboration with Capstone Partners.

Prior to joining NanoVic, Jeanette held roles in two Biotechnology companies in the UK. As Senior Biosensor Scientist at Sphere Medical Ltd (Cambridge, England), she was responsible for developing the enzyme-based biosensor component of the companies Proxima medical detection system. During her time at Applied Enzyme Technology (Pontypool, Wales), Jeanettes role as Senior Project Leader involved commercialisation of biosensor devices, in addition to business development activities and laboratory/project management.

Major Qualifications

Jeanettes academic background was focused on electrochemical biosensor devices for medical and environmental applications. Her PhD, awarded in 2000, and subsequent post-doctoral role at the University of Newcastle upon Tyne entailed the development of lateral flow clinical devices for the quantitative measurement of cardiac marker proteins, such as myoglobin and fatty acid binding protein (FABP).

Commercial Details

Fee Charging structure and rates

Please contact for further information.


Availability and preferred contact route


Current availability status


Ask A Question

Do you have a question you'd like to ask this Expert?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.